Douglas Hussey

1.7k total citations
28 papers, 1.4k citations indexed

About

Douglas Hussey is a scholar working on Radiology, Nuclear Medicine and Imaging, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Douglas Hussey has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Douglas Hussey's work include Neurotransmitter Receptor Influence on Behavior (7 papers), Medical Imaging Techniques and Applications (6 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Douglas Hussey is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (7 papers), Medical Imaging Techniques and Applications (6 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Douglas Hussey collaborates with scholars based in Canada, Austria and United States. Douglas Hussey's co-authors include Sylvain Houle, Alan A. Wilson, Nathalie Ginovart, Jeffrey H. Meyer, Shitij Kapur, Mark Guttman, Alan E. Wilson, Stephen J. Kish, Ur Metser and N. Praschak-Rieder and has published in prestigious journals such as Neurology, Biological Psychiatry and Molecular Psychiatry.

In The Last Decade

Douglas Hussey

27 papers receiving 1.3k citations

Peers

Countries citing papers authored by Douglas Hussey

Since Specialization

Citations

This map shows the geographic impact of Douglas Hussey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Hussey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Hussey more than expected).

Fields of papers citing papers by Douglas Hussey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Hussey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Hussey. The network helps show where Douglas Hussey may publish in the future.

Co-authorship network of co-authors of Douglas Hussey

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Hussey. A scholar is included among the top collaborators of Douglas Hussey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Hussey. Douglas Hussey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	18F-DCFPyL PET/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study 2022 ·Frontiers in Oncology ·Ur Metser, (unknown), Tanya Chawla, Sarah J. Johnson, Lisa Avery, Douglas Hussey, Patrick Veit‐Haibach, Marcus Q. Bernardini, Liat Hogen	2
2	[ ¹⁸ F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial 2020 ·BMJ Open ·Rachel Glicksman, Ur Metser, John F. Valliant, Peter Chung, Neil Fleshner, Robert G. Bristow, David Green, Antonio Finelli, Robert J. Hamilton, (unknown), Douglas Hussey, Charles Catton, Mary Gospodarowicz, Padraig Warde, Andrew Bayley, Stephen Breen, (unknown), David A. Jaffray, Alejandro Berlín	6
3	18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival 2018 ·Annals of Nuclear Medicine ·(unknown), Noam Tau, Douglas Hussey, Manjula Maganti, Ur Metser	66
4	18F-FDG PET/CT in the management of patients with malignant pleural mesothelioma being considered for multimodality therapy: experience of a tertiary referral center 2018 ·British Journal of Radiology ·(unknown), Ur Metser, Marc de Perrot, John Cho, Penelope A. Bradbury, Patrick Veit‐Haibach, Douglas Hussey, Noam Tau	9
5	Effect of chemotherapy on the impact of FDG-PET/CT in selection of patients for surgical resection of colorectal liver metastases: single center analysis of PET-CAM randomized trial 2016 ·Annals of Nuclear Medicine ·Ur Metser, (unknown), Deanna L. Langer, Ravi Mohan, Douglas Hussey, Hadas Moshonov, (unknown)	0
6	Non-cutaneous melanoma: is there a role for¹⁸F-FDG PET-CT? 2014 ·British Journal of Radiology ·(unknown), Douglas Hussey, Ur Metser	12
7	Impact of¹⁸F-FDG PET/CT on the staging and management of follicular lymphoma 2014 ·British Journal of Radiology ·Ur Metser, Douglas Hussey, (unknown)	19
8	Novel 5-HTTLPR Allele Associates with Higher Serotonin Transporter Binding in Putamen: A [11C] DASB Positron Emission Tomography Study 2007 ·Biological Psychiatry ·N. Praschak-Rieder, James L. Kennedy, Alan A. Wilson, Douglas Hussey, (unknown), Matthäus Willeit, Nathalie Ginovart, Subi Tharmalingam, Mario Masellis, Sylvain Houle, Jeffrey H. Meyer	171
9	Effects of Tryptophan Depletion on the Serotonin Transporter in Healthy Humans 2005 ·Biological Psychiatry ·N. Praschak-Rieder, Alan A. Wilson, Douglas Hussey, (unknown), (unknown), Nathalie Ginovart, Markus Schwarz, J. Zach, Sylvain Houle, Jeffrey H. Meyer	71
10	Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor–treated depression: An [18F] MPPF positron emission tomography study 2004 ·Biological Psychiatry ·N. Praschak-Rieder, Douglas Hussey, Alan A. Wilson, (unknown), (unknown), Edward J. Dunn, Matthäus Willeit, R. Michael Bagby, Sylvain Houle, Jeffrey H. Meyer	31
11	Brain Serotonin 5-HT1A Receptor Binding in Schizophrenia Measured by Positron Emission Tomography and [11C]WAY-100635 2002 ·Archives of General Psychiatry ·J. Tauscher, Shitij Kapur, Nicholaas Paul L.G. Verhoeff, Douglas Hussey, Zafiris J. Daskalakis, Sitra Tauscher‐Wisniewski, Alan A. Wilson, Sylvain Houle, Siegfried Kasper, Robert B. Zipursky	111
12	Dopamine depletion results in increased neostriatal D2 receptor binding in humans 2002 ·Molecular Psychiatry ·Nicolaas P. L. G. Verhoeff, J. Tauscher, Corey Jones, Douglas Hussey, (unknown), George Papatheodorou, Alan A. Wilson, Sylvain Houle, Shitij Kapur	17
13	Dopamine depletion results in increased neostriatal D2, but not D1, receptor binding in humans 2002 ·Molecular Psychiatry ·Nicolaas P. L. G. Verhoeff, Douglas Hussey, (unknown), J. Tauscher, George Papatheodorou, Alan A. Wilson, Sylvain Houle, Shitij Kapur	39
14	Imaging cAMP-specific phosphodiesterase-4 in human brain with R -[ 11 C]rolipram and positron emission tomography 2002 ·European Journal of Nuclear Medicine and Molecular Imaging ·Jean N. DaSilva, Célia Lourenço, (unknown), Douglas Hussey, W. D. Potter, Sylvain Houle	40
15	Influence of l -dopa and pramipexole on striatal dopamine transporter in early PD 2001 ·Neurology ·Mark Guttman, Donna E. Stewart, Douglas Hussey, Alan E. Wilson, Sylvain Houle, Stephen J. Kish	124
16	A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT2A receptor changes in schizophrenia 2000 ·Psychiatry Research Neuroimaging ·Nicholaas Paul L.G. Verhoeff, Jeffrey H. Meyer, Aleksandar Kecojević, Douglas Hussey, (unknown), J. Tauscher, Robert B. Zipursky, Shitij Kapur	39
17	Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB 2000 ·European Journal of Nuclear Medicine and Molecular Imaging ·Sylvain Houle, Nathalie Ginovart, Douglas Hussey, Jeffrey H. Meyer, Alan A. Wilson	233
18	Contributions of the mesial frontal cortex to the premovement potentials associated with intermittent hand movements in humans 1996 ·Human Brain Mapping ·Colum D. MacKinnon, Shitij Kapur, Douglas Hussey, Mary C. Verrier, Sylvain Houle, W. G. Tatton	36
19	In vivo binding of [11C]SKF 75670 and [11C]SKF 82957 in rat brain: Two dopamine D-1 receptor agonist ligands 1996 ·Life Sciences ·Jean N. DaSilva, Alan A. Wilson, (unknown), Douglas Hussey, David M. Wilson, Sylvain Houle	5
20	Absence of residual effects after physiological stimulation of the visual and motor cortex 1994 ·Nuclear Medicine Communications ·Sylvain Houle, Shitij Kapur, (unknown), Douglas Hussey, Douglas R. Wilson	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact